ACCESS BIOTECHNOLOGY

access-biotechnology-logo

Access Biotechnology is the life science investment arm of Access Industries. They invest in transformative therapies for conditions with high unmet needs and that have the potential to meaningfully impact human health. They invest in both private and public biopharma companies across therapeutic areas, modalities, and development stages – from discovery-stage technology platforms to late-stage clinical programs. The company is based in New York.

#SimilarOrganizations #People #Financial #More

ACCESS BIOTECHNOLOGY

Social Links:

Industry:
Biopharma Biotechnology Health Care Life Science

Founded:
1986-01-01

Status:
Active

Contact:
(212) 247-6400

Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible Google Font API WordPress Apache Sitelinks Search Box Yoast WordPress SEO Plugin Yoast SEO Premium Yoast Plugins PHP


Similar Organizations

enzyvant-sciences-logo

Enzyvant Sciences

Enzyvant Sciences is a biotechnology company which focuses on developing treatments for rare diseases.

pci-pharma-services-logo

PCI Pharma Services

PCI Pharma Services is a provider of outsourced services to the global pharmaceutical market.

penn-medicine-co-investment-program-logo

Penn Medicine Co-Investment Program

Penn Medicine Co-Investment Program makes investments in faculty-driven cell therapy, gene therapy, and connected health companies

Current Employees Featured

dan-becker_image

Dan Becker
Dan Becker Principal @ Access Biotechnology
Principal

christine-borowski_image

Christine Borowski
Christine Borowski Senior Associate @ Access Biotechnology
Senior Associate

liam-ratcliffe_image

Liam Ratcliffe
Liam Ratcliffe Head of Biotechnology @ Access Biotechnology
Head of Biotechnology

jeffrey-ives_image

Jeffrey Ives
Jeffrey Ives Advisor @ Access Biotechnology
Advisor
2021-01-01

Investments List

Date Company Article Money raised
2022-08-10 Disc Medicine Access Biotechnology investment in Venture Round - Disc Medicine N/A
2022-07-12 Areteia Therapeutics Access Biotechnology investment in Series A - Areteia Therapeutics 350 M USD
2022-06-02 Upstream Bio Access Biotechnology investment in Series A - Upstream Bio 200 M USD
2021-12-01 Curie Therapeutics Access Biotechnology investment in Series A - Curie Therapeutics 75 M USD
2021-11-15 Recludix Pharma Access Biotechnology investment in Series A - Recludix Pharma 60 M USD
2021-09-02 Disc Medicine Access Biotechnology investment in Series B - Disc Medicine 90 M USD
2021-07-13 Nimbus Therapeutics Access Biotechnology investment in Venture Round - Nimbus Therapeutics 105 M USD
2021-05-24 Eliem Therapeutics Access Biotechnology investment in Series B - Eliem Therapeutics 60 M USD
2021-03-25 Eliem Therapeutics Access Biotechnology investment in Series A - Eliem Therapeutics 80 M USD
2021-03-01 DTx Pharma Access Biotechnology investment in Series B - DTx Pharma 100 M USD

More informations about "Access Biotechnology" on Search Engine